Atlas Trials

Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine

Clinical trial NCT02823899 · COMPLETED

Trial details

NCT number
NCT02823899
Sponsor
International Centre for Diarrhoeal Disease Research, Bangladesh
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cholera
Start date
2016-07-01
Primary completion
2017-11-01
Enrollment
840

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.